The cigarette-smoking behavior of 840 patients with resected Stage I non-small cell lung cancer was analyzed prospectively for up to four years following diagnosis. Lung cancer patients were heavier smokers at diagnosis than other cancer patients and the general population. At one year, only 16.8 percent of the 317 current smokers at baseline, who were followed for two years or longer, continued to smoke, while 83.2 percent of patients either quit permanently (53.0 percent) or for some time period (30.2 percent). By two years, permanent cessation stabilized at over 40 percent; however, the prevalence of continuing smoking decreased through all periods of follow-up. Subjects who tried to quit or did quit permanently were more likely to be female and healthier than continuous smokers.
Similar content being viewed by others
References
US Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. Rockville MD: US Department of Health and Human Services, Public Health Service, Office on Smoking and Health, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, 1989, DHSS Pub. No. (CDC) 89–8411.
American Cancer Society. Cancer Facts and Figures—1990. Atlanta: American Cancer Society, 1990.
DavisonG, DuffyM. Smoking habits of long-term survivors of surgery for lung cancer. Thorax 1982; 37: 331–3.
KnudsenN, SchulmanS, Van denHoekJ, FowlerR. Insights on how to quit smoking: A survey of patients with lung cancer. Cancer Nurs 1985; 8: 145–50.
Johnston-EarlyA, CohenMH, MinnaJD, et al. Smoking abstinence and small cell lung cancer survival. JAMA 1980; 244: 2175–9.
GailMH, EaganRT, FeldR, et al. The Lung Cancer Study Group. Prognostic factors in patients with resected Stage I non-small cell lung cancer. Cancer 1984; 54: 1802–13.
US Department of Health and Human Services. The Health Consequences of Smoking. Nicotine Addiction. A Report of the Surgeon General. Rockville MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health, 1988; DHHS Pub. No. (CDC) 88–8406.
ThomasPA, PiantadosiS. Postoperative T1N0 non-small cell lung cancer: Squamous versus non squamous recurrences. J Thorac Cardiovasc Surg 1987; 94: 349–54.
Spitz M. Personal communication, 16 November 1990.
Crane LA. Unpublished analysis of 1978–80 National Health Interview Survey Public Use Data Tapes, University of California, Los Angeles, 1990.
BurlingTA, SingletonGE, BigelowGE, BaileWF, GottliebSH. Smoking following myocardial infarction: A critical review of the literature. Health Psychol 1984; 3: 83–96.
US Department of Health and Human Services. The Health Consequences of Smoking: Chronic Obstructive Lung Disease. A Report of the Surgeon General. Rockville MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General, Office on Smoking and Health, 1984, DHSS Pub. No. (PHS) 84–50205.
SpitzMR, FuegerJJ, ChamberlainRM, GoepfertH, NewellGR. Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. J Cancer Educ 1990; 5: 109–13.
MountainCF, LukemanJM, HammarSP, et al. Lung cancer classification: the relationships of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 1987; 35: 147–56.
Gritz ER. Smoking and smoking cessation in cancer patients. Br J Addict (in press).
BeckerMH, MaimanLA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975; 13: 10–24.
BeckerMH, MaimanLA. Strategies for enhancing patient compliance. J Community Health 1980; 6: 113–35.
DiMatteoMR, DiNicolaDD. Achieving Patient Compliance: The Psychology of the Medical Practitioner's Role. New York: Pergamon Press, 1982.
GritzER, WardPH, BeumerJJr, CarrCR, RapkinD. Increasing adherence to a provider-delivered smoking cessation intervention for head and neck cancer patients. In: EngstromPF, RimerB, MortensenLE, eds. Advances in Cancer Control: Screening and Prevention Research. New York: Wiley-Liss, Inc., 1990. 83–93.
PetittiDB, FriedmanGD, KahnW. Accuracy of information on smoking habits provided on self-administered research questionnaires. Am J Public Health 1981; 71: 308–11.
PojerR, WhitfieldJB, PoulosV, EckhardIF, RichmondR, HensleyWJ. Carboxyhemoglobin, cotinine, and thiocyanate assay compared for distinguishing smokers from nonsmokers. Clin Chem 1984; 30: 1377–80.
FortmannSP, RogersT, VranizanK, HaskellWL, SolomonDS, FarquharJW. Indirect measures of cigarette use: Expired-air carbon monoxide versus plasma thiocyanate. Prev Med 1984; 13: 127–35.
PierceJP, DwyerT, DiGiustoE, et al. Cotinine validation of self-reported smoking in commercially run community surveys. J Chronic Dis 1987; 40: 689–95.
HarberP, TashkinD, ShimozakiS, HathawayE. Veracity of disability claimants' self-reports of current smoking status. Chest 1988; 93: 561–4.
NeatonJ, BrosteS, CohenL, FishmanE, KjelsbergM, SchoenbergerJ. The multiple risk factor intervention trial (MRFIT): VII. A comparison of risk factor changes between the two study groups. Prev Med 1981; 10: 519–43.
OhlinP, LundhB, WestlingH. Carbon monoxide blood levels and reported cessation of smoking. Psychopharmacology 1976; 49: 263–5.
SillettR, WilsonM, MalcomR, BallK. Deception among smokers. Br Med J 1978; 2: 1185–6.
WilcoxR, HughesJ, RolandJ. Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J 1979; 2: 1026–8.
SpitzMR, FuegerJJ, EriksenMP, NewellJR. Cigarette smoking patterns of cancer patients. In: EngstromPF, RimerB, MortensenLE, eds. Advances in Cancer Control: Screening and Prevention Research. New York: Wiley-Liss, Inc., 1990. 73–82.
Author information
Authors and Affiliations
Additional information
This research was supported in part by grants CA 43461, CA-16042, and CA-3417 from the National Cancer Institute.
Rights and permissions
About this article
Cite this article
Gritz, E.R., Nisenbaum, R., Elashoff, R.E. et al. Smoking behavior following diagnosis in patients with Stage I non-small cell lung cancer. Cancer Causes Control 2, 105–112 (1991). https://doi.org/10.1007/BF00053129
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00053129